Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca C Coll

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Science (New York, N.Y.)|June 18, 2016
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cellsGiuseppina Arbore, Erin E West, Rosanne Spolski, et al.
Diabetes|January 29, 2015
Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesityOrla M Finucane, Claire L Lyons, Aoife M Murphy, et al.
Nature Immunology|September 14, 2010
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesSeth L Masters, Aisling Dunne, Shoba L Subramanian, et al.
Nature Medicine|February 17, 2015
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesRebecca C Coll, Avril A B Robertson, Jae Jin Chae, et al.
The Journal of Experimental Medicine|September 2, 2025
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of actionKevin Wilhelmsen, Aditi Deshpande, Sarah Tronnes, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Science (New York, N.Y.)|June 18, 2016
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cellsGiuseppina Arbore, Erin E West, Rosanne Spolski, et al.
Diabetes|January 29, 2015
Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesityOrla M Finucane, Claire L Lyons, Aoife M Murphy, et al.
Nature Immunology|September 14, 2010
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesSeth L Masters, Aisling Dunne, Shoba L Subramanian, et al.
Nature Medicine|February 17, 2015
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesRebecca C Coll, Avril A B Robertson, Jae Jin Chae, et al.
The Journal of Experimental Medicine|September 2, 2025
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of actionKevin Wilhelmsen, Aditi Deshpande, Sarah Tronnes, et al.
Pageof 4